Coronary Heart Disease Prediction From Lipoprotein Cholesterol Levels, Triglycerides, Lipoprotein(a), Apolipoproteins A-I and B, and HDL Density Subfractions: The Atherosclerosis Risk in Communities…

By A. Sharrett, Christie M. Ballantyne, S. Coady, G. Heiss, P. Sorlie, Diane Catellier, W. Patsch. Circulation, 2001

1,001 citations recorded by the source corpus.

Subfields: Clinical Biochemistry, Endocrinology, Diabetes and Metabolism, Surgery

View Paper: https://www.semanticscholar.org/paper/52eaf58909271e9a5199306504b42d31c95c6d84

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Clinical Biochemistry

1. R. Goldberg

In Endocrinology, Diabetes and Metabolism

1. J. Chapman
2. R. Goldberg
3. A. Kontush

In Surgery

1. J. Chapman
2. R. Goldberg
3. A. Kontush
4. P. Calder

Citations in the corpus

• Triglycerides and the Risk of Coronary Heart Disease: 10 158 Incident Cases Among 262 525 Participants in 29 Western Prospective Studies (2007, neutral): “History of diabetes, n (%) 23 (2) 18 (1) 25 (2) 0.01 0.7 1.1 12 ( 2 ) 12 (2) 16 (2) 0.04 1.8 1.0”
• Lipoprotein Management in Patients With Cardiometabolic Risk (2008, background): “Measurements of HDL subfractions or apoA1 appear to provide little clinical value beyond measurements of HDL cholesterol (49).”
• Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis (2006, background): “, 2004)) constitute an independent risk factor for coronary heart disease (CHD) in both nondiabetic and diabetic subjects (Maron, 2000; Sharrett et al., 2001; Gotto and Brinton, 2004).”